Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 10 studies | 48% ± 25% | |
| GABAergic neuron | 6 studies | 49% ± 20% | |
| neuron | 4 studies | 23% ± 5% | |
| endothelial cell | 4 studies | 29% ± 12% | |
| interneuron | 4 studies | 51% ± 23% | |
| GABAergic interneuron | 3 studies | 28% ± 3% | |
| retinal ganglion cell | 3 studies | 20% ± 3% | |
| retina horizontal cell | 3 studies | 31% ± 2% | |
| endothelial cell of lymphatic vessel | 3 studies | 17% ± 2% | |
| pericyte | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 8 studies | 39% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 3769.50 | 2586 / 2642 | 97% | 9.06 | 681 / 705 |
| thymus | 93% | 926.73 | 605 / 653 | 98% | 10.12 | 595 / 605 |
| adrenal gland | 85% | 729.23 | 219 / 258 | 86% | 11.86 | 198 / 230 |
| esophagus | 75% | 880.20 | 1087 / 1445 | 84% | 7.24 | 154 / 183 |
| kidney | 90% | 1373.57 | 80 / 89 | 66% | 3.15 | 597 / 901 |
| intestine | 50% | 338.25 | 479 / 966 | 92% | 12.01 | 487 / 527 |
| breast | 76% | 879.01 | 347 / 459 | 60% | 2.40 | 666 / 1118 |
| lung | 67% | 534.04 | 390 / 578 | 55% | 3.04 | 638 / 1155 |
| pancreas | 16% | 97.54 | 54 / 328 | 92% | 10.09 | 164 / 178 |
| muscle | 100% | 24238.73 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 4042.66 | 241 / 241 | 0% | 0 | 0 / 0 |
| stomach | 12% | 75.00 | 43 / 359 | 84% | 9.60 | 239 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 8.84 | 42 / 45 |
| adipose | 90% | 1175.93 | 1083 / 1204 | 0% | 0 | 0 / 0 |
| skin | 71% | 813.14 | 1289 / 1809 | 18% | 0.81 | 83 / 472 |
| uterus | 13% | 83.38 | 22 / 170 | 71% | 5.84 | 326 / 459 |
| bladder | 38% | 218.86 | 8 / 21 | 44% | 4.37 | 220 / 504 |
| heart | 63% | 546.72 | 542 / 861 | 0% | 0 | 0 / 0 |
| ovary | 2% | 9.77 | 3 / 180 | 56% | 2.29 | 239 / 430 |
| blood vessel | 56% | 432.65 | 743 / 1335 | 0% | 0 | 0 / 0 |
| prostate | 25% | 269.89 | 61 / 245 | 28% | 0.94 | 141 / 502 |
| liver | 1% | 6.47 | 2 / 226 | 43% | 2.79 | 176 / 406 |
| eye | 0% | 0 | 0 / 0 | 18% | 0.60 | 14 / 80 |
| peripheral blood | 1% | 13.31 | 12 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007010 | Biological process | cytoskeleton organization |
| GO_0030032 | Biological process | lamellipodium assembly |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0051015 | Molecular function | actin filament binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ABLIM2 |
| Protein name | Actin-binding LIM protein 2 (abLIM-2) (Actin-binding LIM protein family member 2) Actin binding LIM protein family member 2 Actin-binding LIM protein 2 splice variant 1 Uncharacterized protein ABLIM2 |
| Synonyms | KIAA1808 |
| Description | FUNCTION: May act as scaffold protein. May stimulate ABRA activity and ABRA-dependent SRF transcriptional activity. . |
| Accessions | A0AA34QVK8 D6RAL0 Q4W5G4 ENST00000447017.7 [Q6H8Q1-9] ENST00000505872.5 [Q6H8Q1-7] ENST00000361737.9 [Q6H8Q1-3] ENST00000514025.5 [Q6H8Q1-4] ENST00000510277.1 ENST00000676532.1 ENST00000407564.7 [Q6H8Q1-8] Q19VH1 ENST00000361581.9 [Q6H8Q1-2] ENST00000545242.6 ENST00000710854.1 ENST00000428004.6 [Q6H8Q1-6] F5GYR0 ENST00000341937.9 [Q6H8Q1-1] A0A7I2V5G9 Q6H8Q1 |
